Khaitan & Co acted as Legal Counsel as to Indian Law to the Book Running Lead Managers (Axis Capital Limited, IIFL Securities Limited, JM Financial Limited and SBI Capital Markets Limited) in relation to the proposed initial public offering of Rubicon Research Limited aggregating to INR 10,850 million.
The core team consisted of Subhayu Sen (Partner), Aayush Mohata, Partner, Aparna Bagree, Principal Associate, Johann Valladares, Senior Associate, Aayush Virani, Associate and Shreya Iyer, Associate.
The company is a pharmaceutical formulations company, focused research and development, with a portfolio of specialty products and drug-device combination products targeting regulated markets, particularly, the United States. Based on the peer set, the company is the only Indian pharmaceutical player with a complete focus on regulated markets.
 (850 x 600 px) (39)_20241121094035_original_image_43.webp)
 (850 x 600 px) (36)_20241121064948_original_image_30.webp)
_20241121060428_original_image_48.webp)
_20241119125218_original_image_42.webp)
